SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs > Intellipharmaceutics International Inc. (IPCI)

Hey Doog, long time no see, lol. Just

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
dtstx Member Profile
 
Followed By 18
Posts 2,282
Boards Moderated 0
Alias Born 07/09/06
160x600 placeholder
Statement of Ownership (sc 13g) "Edgar (US Regulatory)" - 10/20/2017 5:20:34 PM
Small Company Offering and Sale of Securities Without Registration (d) "Edgar (US Regulatory)" - 10/18/2017 3:20:22 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 10/16/2017 6:03:43 AM
Intellipharmaceutics Announces Closing of US$4 Million Financing "GlobeNewswire Inc." - 10/13/2017 5:45:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 10/13/2017 6:04:15 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 10/12/2017 4:07:48 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 10/11/2017 8:07:45 AM
Intellipharmaceutics Announces US$4 Million Registered Direct Offering "GlobeNewswire Inc." - 10/11/2017 8:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 10/10/2017 5:25:56 PM
Intellipharmaceutics Announces Third Quarter 2017 Results "GlobeNewswire Inc." - 10/10/2017 5:20:59 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 9/25/2017 7:12:00 AM
Intellipharmaceutics Receives Complete Response Letter from the FDA for Rexista™ NDA "GlobeNewswire Inc." - 9/25/2017 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 9/20/2017 5:18:47 PM
Intellipharmaceutics Announces Receipt of Nasdaq Notice "GlobeNewswire Inc." - 9/20/2017 5:10:00 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 9/5/2017 2:43:50 PM
Intellipharmaceutics Provides Operational Update "GlobeNewswire Inc." - 9/5/2017 2:35:00 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 9/1/2017 8:10:22 AM
Intellipharmaceutics Appoints New Chief Financial Officer "GlobeNewswire Inc." - 9/1/2017 8:00:00 AM
Monteverde & Associates PC Invites IntelliPharmaCeutics International Inc. Shareholders with Losses in Excess of $1... "PR Newswire (US)" - 8/15/2017 4:52:00 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 8/8/2017 3:06:36 PM
Intellipharmaceutics Announces Resignation of Chief Financial Officer "GlobeNewswire Inc." - 8/8/2017 3:00:00 PM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 7/31/2017 8:10:21 AM
Intellipharmaceutics Intends to Vigorously Defend Recently Filed Purported Class Action Lawsuit "GlobeNewswire Inc." - 7/31/2017 8:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 7/27/2017 6:07:34 AM
Intellipharmaceutics Provides Update on FDA Advisory Committees Meeting for Rexista™ (oxycodone hydrochloride extended rele... "GlobeNewswire Inc." - 7/26/2017 8:15:00 PM
dtstx   Wednesday, 11/08/17 12:34:52 PM
Re: doogdilinger post# 31168
Post # of 31352 
Hey Doog, long time no see, lol. Just checking in as we both had been in this company for 5-6yrs. I had made the decision to unload completely upon the Glucophage acceptance run-up on 2-24-17, in the 2.55-2.85 range. Coincidentally that was 1 yr. to the day that the Keppra acceptance was announced with no movement on commercialization of that product. I wasn't optimistic about Glucophage fairing any better with the companies history. At my peak I had well over 300k shares so the run-up helped me unload as we were around the $2 range previously.

I had bowed out gracefully still hoping this company could turn the corner for the sake of the good people still invested here. I will say for the record I did not envision the Adcom results but it most certainly reflects a pattern.

I guess for me, being invested in a company for so long, I let my vision cloud my better judgement. That being said my best to those still invested here. I think new money can make a profit at these levels in due time.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist